Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation

被引:0
作者
Yanagisawa, Ryu [1 ]
Koyama, Hiroaki [2 ]
Yakushijin, Kimikazu [3 ]
Uchida, Naoyuki [4 ]
Jinguji, Atsushi [5 ]
Takeda, Wataru [6 ]
Nishida, Tetsuya [7 ]
Tanaka, Masatsugu [8 ]
Eto, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Ikegame, Kazuhiro [11 ]
Matsuoka, Ken-ichi [12 ]
Katayama, Yuta [13 ,14 ]
Kanda, Yoshinobu [15 ]
Sawa, Masashi [16 ]
Kawakita, Toshiro [17 ]
Onizuka, Makoto [18 ]
Fukuda, Takahiro [6 ]
Atsuta, Yoshiko [19 ,20 ]
Shinohara, Akihito [2 ]
Nakasone, Hideki [15 ,21 ]
机构
[1] Shinshu Univ Hosp, Div Blood Transfus, Matsumoto, Japan
[2] Tokyo Womens Med Univ, Dept Hematol, Tokyo, Japan
[3] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Japan
[4] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[6] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[7] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[8] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Japan
[9] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Hyogo Med Univ Hosp, Dept Hematol, Nishinomiya, Japan
[12] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[13] Hiroshima Red Cross Hosp, Dept Hematol, Hiroshima, Japan
[14] Atom Bomb Survivors Hosp, Hiroshima, Japan
[15] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[16] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[17] Natl Hosp Org, Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan
[18] Tokai Univ, Dept Hematol & Oncol, Sch Med, Isehara, Japan
[19] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagakute, Japan
[20] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
[21] Jichi Med Univ, Ctr Mol Med, Div Emerging Med Integrated Therapeut, Shimotsuke, Japan
关键词
CHRONIC KIDNEY-DISEASE; LONG-TERM SURVIVORS; COMORBIDITY INDEX; INJURY; HCT; IMPACT; PATHOGENESIS; DYSFUNCTION; MORTALITY; GVHD;
D O I
10.1038/s41409-023-02172-4
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Various complications can influence hematopoietic cell transplantation (HCT) outcomes. Renal complications can occur during the early to late phases of HCT along with various factors. However, studies focusing on fatal renal complications (FRCs) are scarce. Herein, we analyzed 36,596 first allogeneic HCT recipients retrospectively. Overall, 782 patients died of FRCs at a median of 108 (range, 0-3,440) days after HCT. The cumulative incidence of FRCs was 1.7% and 2.2% at one and five years, respectively. FRCs were associated with older age, male sex, non-complete remission (non-CR), lower performance status (PS), and HCT comorbidity index (HCT-CI) associated with renal comorbidity in multivariate analysis. The risk factors within 100 days included older age, multiple myeloma, PS, and HCT-CI comorbidities (psychiatric disturbance, hepatic disease, obesity, and renal disease). Older age and male sex were risk factors between 100 days and one year. After one year, HCT-CI was associated with the presence of diabetes and prior solid tumor; total body irradiation was identified as a risk factor. Non-CR was a common risk factor in all three phases. Furthermore, acute and chronic graft-versus-host disease, reactivation of cytomegalovirus, and relapse of underlying disease also affected FRCs. Systematic follow-up may be necessary based on the patients' risk factors and post-HCT events.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [21] Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JS']JSTCT, Transplant Complications Working Group
    Saburi, Masuho
    Oshima, Kumi
    Takano, Kuniko
    Inoue, Yoshitaka
    Harada, Kaito
    Uchida, Naoyuki
    Fukuda, Takahiro
    Doki, Noriko
    Ikegame, Kazuhiro
    Matsuo, Yayoi
    Katayama, Yuta
    Ozawa, Yukiyasu
    Matsuoka, Ken-ichi
    Kawakita, Toshiro
    Mori, Yasuo
    Ara, Takahide
    Nakamae, Hirohisa
    Kimura, Takafumi
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Ogata, Masao
    ANNALS OF HEMATOLOGY, 2023, 102 (09) : 2507 - 2516
  • [22] Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
    Skoczen, Szymon
    Bik-Multanowski, Miroslaw
    Pietrzyk, Jacek J.
    Grabowska, Agnieszka
    Fijorek, Kamil
    Strojny, Wojciech
    Klus-Kwiecinska, Kinga
    Balwierz, Walentyna
    Siedlar, Maciej
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [23] Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation
    Mo Xiao-dong
    Xu Lan-ping
    Liu Dai-hong
    Zhang Xiao-hui
    Chen Huan
    Chen Yu-hong
    Han Wei
    Wang Yu
    Wang Feng-rong
    Wang Jing-zhi
    Liu Kai-yan
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2013, 126 (13) : 2489 - 2494
  • [24] Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications
    Morishita, Takanobu
    Okabe, Motohito
    Kawaguchi, Yuuka
    Lee, Yoonha
    Ohbiki, Marie
    Osaki, Masahide
    Goto, Miyo
    Araie, Hiroaki
    Sato, Takahiko
    Goto, Tatsunori
    Ozawa, Yukiyasu
    Miyamura, Koichi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (12) : 2509 - 2516
  • [25] Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation
    Bieri, Sabine
    Roosnek, Eddy
    Ozsahin, Hulya
    Huguet, Saadia
    Ansari, Marc
    Trombetti, Andrea
    Helg, Claudine
    Chapuis, Bernard
    Miralbell, Raymond
    Passweg, Jakob
    Chalandon, Yves
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (02) : 138 - 147
  • [26] Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging
    Sharma, S.
    Leung, W-H
    Deqing, P.
    Yang, J.
    Rochester, R.
    Britton, L.
    Neel, M. D.
    Ness, K. K.
    Kaste, S. C.
    BONE MARROW TRANSPLANTATION, 2012, 47 (08) : 1067 - 1074
  • [27] Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation
    Gilles, Ramona
    Herling, Marco
    Holtick, Udo
    Heger, Eva
    Awerkiew, Sabine
    Fish, Irina
    Hoeller, Konstantin
    Sierra, Saleta
    Knops, Elena
    Kaiser, Rolf
    Scheid, Christof
    Di Cristanziano, Veronica
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2017, 206 (05) : 355 - 362
  • [28] Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation
    Ramona Gilles
    Marco Herling
    Udo Holtick
    Eva Heger
    Sabine Awerkiew
    Irina Fish
    Konstantin Höller
    Saleta Sierra
    Elena Knops
    Rolf Kaiser
    Christof Scheid
    Veronica Di Cristanziano
    Medical Microbiology and Immunology, 2017, 206 : 355 - 362
  • [29] Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation
    Bhandari, Rusha
    The, Jennifer Berano
    He, Tianhui
    Nakamura, Ryotaro
    Artz, Andrew S.
    Jankowska, Marta M.
    Forman, Stephen J.
    Wong, F. Lennie
    Armenian, Saro H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (11): : 1484 - 1491
  • [30] Complications after allogeneic bone marrow and stem cell transplantation
    Wollmer, E.
    Neubauer, A.
    INTERNIST, 2014, 55 (05): : 547 - 560